Skip to main content

Alnylam stock hits all-time high on amyloidosis drug data

Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY) stock hit an all-time high Thursday after the biotech announced “robust and statistically significant” effectiveness of its injectable drug candidate for amyloidosis in an early-stage trial...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.